Collectively, this indicates that a subset of KMT2A-fusion target genes continued to be regulated by DOT1L in pinometostat-resistant ALL cells, while a separate group of genes showed no transcriptional response to the inhibition of DOT1L-mediated H3K79 methylation. The gene discussed is DOT1L; the disease is acute lymphoblastic leukemia.